Newsletter

Pol. Merkur. Lek (Pol. Med. J.), 2016, XL/236: 129-133 Maximize

Pol. Merkur. Lek (Pol. Med. J.), 2016, XL/236: 129-133

Title: Post-Lyme disease syndrome 

Authors: Błaut-Jurkowska J, Jurkowski M. 

More details

12/236

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

Post-Lyme disease syndrome


Błaut-Jurkowska J, Jurkowski M.

Non-public Health Care Center, Kłaj, Poland

Lyme disease is a chronic infectious disease caused by the bacteria, spirochete of the Borrelia type. Skin, nervous system, musculoskeletal system and heart may be involved in the course of the disease. The prognosis for properly treated Lyme disease is usually good. However, in about 5% of patients so called Post-Lyme disease syndrome (PLSD) develops. It is defined as a syndrome of subjective symptoms persisting despite proper treatment of Borrelia burgdorferi infection. The most common symptoms include: fatigue, muscle and joint pain, and problems with memory and concentration. Pathogenesis of PLDS remains unknown. The differential diagnosis should include neurological, rheumatic and mental diseases. Till now there is no causative treatment of PLDS. In relieving symptom rehabilitation, painkillers, anti-inflammatory and antidepressants medicines are recommended. Emotional and psychological supports are also necessary. Non-specific symptoms reported by patients with post- Lyme disease syndrome raise the suspicion of other pathologies. This can lead to misdiagnosis and implementation of unnecessary, potentially harmful to the patient’s therapy. An increase in tick-borne diseases needs to increase physicians awareness of these issues.

Key words: post-Lyme disease syndrome (PLDS), Borrelia burgdorferi

Pol Med J, 2016; XL (236); 129–133